Human CYPs: In vivo and clinical aspects

被引：26

作者：

Pelkonen, O ^{[1
]}

机构：

[1] Univ Oulu, Dept Pharmacol & Toxicol, FIN-90014 Oulu, Finland

来源：

DRUG METABOLISM REVIEWS | 2002年 / 34卷 / 1-2期

关键词：

D O I：

10.1081/DMR-120001388

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：37 / 46

页数：10

共 33 条

[1] UPDATE ON RIFAMPIN DRUG-INTERACTIONS [J].

BACIEWICZ, AM ;

SELF, TH ;

BEKEMEYER, WB .

ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (03) :565-568

[2] Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies [J].

Benedetti, MS .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2000, 14 (04) :301-319

[3] IN-VITRO APPROACHES CAN PREDICT HUMAN DRUG-METABOLISM [J].

BIRKETT, DJ ;

MACKENZIE, PI ;

VERONESE, ME ;

MINERS, JO .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (08) :292-294

[4] HUMAN CYTOCHROMES-P-450 [J].

BOOBIS, AR ;

DAVIES, DS .

XENOBIOTICA, 1984, 14 (1-2) :151-185

[5]

Bourrie M, 1996, J PHARMACOL EXP THER, V277, P321

[6] Clinically significant pharmacokinetic interactions between dietary caffeine and medications [J].

Carrillo, JA ;

Benitez, J .

CLINICAL PHARMACOKINETICS, 2000, 39 (02) :127-153

[7]

Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222

[8] BIOCHEMISTRY AND MOLECULAR-BIOLOGY OF THE HUMAN CYP2C SUBFAMILY [J].

GOLDSTEIN, JA ;

DEMORAIS, SMF .

PHARMACOGENETICS, 1994, 4 (06) :285-299

[9]

Guengerich F.P., 1995, ADV DRUG METABOLISM, P179

[10] Cytochrome P-450 3A4: Regulation and role in drug metabolism [J].

Guengrich, FP .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :1-17

← 1 2 3 4 →